Resp - Cystic fibrosis treatment Flashcards

1
Q

What is CF?

A

genetic disorder affecting the lungs, pancreas, liver, intestine, and reproductive organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the signs of CF?

A

pulmonary disease, with recurrent infections and the production of copious viscous sputum, and malabsorption due to pancreatic insufficiency

Complications include hepatobiliary disease, osteoporosis, cystic fibrosis-related diabetes, and distal intestinal obstruction syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aims of treatment

A

Preventing and managing lung infections

Loosening and removing thick, sticky mucus from the lungs

Preventing or treating intestinal obstruction

Providing sufficient nutrition and hydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What function is a key predictor?

A

lung function - optimising lung function is a major aim of care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the Non-Drug Treatment?

A

Provide advice on airway clearance, nebuliser use, musculoskeletal disorders, physical activity, and urinary incontinence (by specialist physiotherapists).
Regular exercise improves both lung function and overall fitness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the Drug Treatment?

A

Treatment is based on the prevention of lung infection and the maintenance of lung function.

Patients, who have clinical evidence of lung disease, the frequency of routine review should be based on their clinical condition.

Adults should be reviewed at least every 3 months.

More frequent review is required immediately after diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mucolytics

A

Patients with cystic fibrosis who have evidence of lung disease should be offered a mucolytic.
Dornase alfais the first choice mucolytic.
If there is an inadequate response,dornase alfaand hypertonicsodium chloride, or hypertonicsodium chloridealone should be considered.
Mannitoldry powder for inhalation is recommended as an option whendornase alfais unsuitable, when lung function is rapidly declining, and if other osmotic drugs are not considered appropriate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Staphylococcus aureus

A

Offer an antibacterial oral or IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pseudomonas aeruginosa

A

Offer an oral antibacterial in combination with an inhaled antibacterial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aspergillus fumigatuscomplex

A

Offer an antifungal drug only to suppresschroniccomplex respiratory infection in patients with declining pulmonary status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Inheritable autosomal _________ disease

A

reccesive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mutations of the cystic fibrosis transmembrane conductance regulator ______ gene

A

CFTR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which systems are affected?

A

Pulmonary and GI systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Epidemiology of CF

A

equally diagnosed in males and females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the most common mutation

A

ΔF508 - a three base-pair deletion that should code for a phenylalanine (position 508)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the main causes

A
  • CFTR gene, found at the q31.2 locus of chromosome 7, is 230,000 base pairs long, and creates a protein that is 1,480 amino acids long.
  • CFTR gene, found at the q31.2 locus of chromosome 7, is 230,000 base pairs long, and creates a protein that is 1,480 amino acids long.

-

17
Q

Cellular processing of CFTR:

A
  1. Synthesis of mRNA (transcription)
  2. translation and folding in the ER (splicing and folding)
  3. Glycosylation and vesicle packaging in the Golgi
  4. Insertion into and retrieval from membrane (stabilioty)
  5. Activation by ATP binding and cAMP-dependent phosphorylation (activity and conductance)
18
Q

CFTR In Cystic Fibrosis

A

CFTR Channel: Chloride ions aren’t transported through chloride channels in CF
Chloride ions – reduced extraceullulary (on surface of epithelium)

Affects constituency of mucus

Na+ and Cl− on airway surfaces
coupled to reduced water flow to the airway lumen
dehydrating mucus
Reduced HCO3− to the airway surface, acidifying layer

19
Q

Diagnosis of CF

A

Large number of CFTR mutations limits utility of DNA tests in diagnosis but can be done
The heel prick test blood test newborns – common variants

Sweat test for chlorine levels (>60mM for adults)

20
Q

How to manage CF?

A
  • Life-style and pyschological support required
  • Maintenance to improve QoL and limit exacerbations
21
Q

Treatment objectives:

A

Promote clearance of secretions

Control lung infection

Provide adequate nutrition

Prevent intestinal obstruction

22
Q

What is the process of CF lung disease?

A
  1. mutations of CFTR gene
  2. ion transport abnormalities
  3. overly viscous mucous
  4. impaired mucous clearance (mucolytics)
  5. infection (antibiotics)&raquo_space; inflammation which leads to tissue damage
23
Q

What happens in a pulmonary mucous clearance??

A

airway surface liquid protects lung and pericilary layer and mucus layer

the PCL is a grafted brush of tethered mucins

and mucus is a visocoelastic fluid

24
Q

What do ASL layers do?

A

trap and clear inhlaed pathogens from lung via mucociliary transport

mucus consistency affects this

ciliary clearence becomes ineffective

25
Q

Inhaled dornase alfa

A

DNA forms polymers thickening mucous
Dornase alfa is a DNAse
Reduces viscosity of mucous

26
Q

Inhaled hypertonic saline

A

Disrupts ionic bonds supporting entanglements
Disassociates DNA from mucous proteins
Improved access to endogenous proteolytics

27
Q

Inhaled mannitol

A

Hydrates mucous
Osmotic mechanism

28
Q

name examples of bronchodialators

A

Commonly used for acute relief of obstruction
No clinical studies on exacerbation

29
Q

Chest physiotherapy

A

Used to aid clearance of mucous from the lungs

30
Q

Oral corticosteroids

A

Reduce rate of decline in lung function
Reduce frequency of infections
Unwanted effects preclude long term use

31
Q

Inhaled corticosteroids

A

Don’t improve lung function unless airway hyperreactivity

32
Q

Pancreatic enzyme supplements

A

Supplements contain protease, lipase and amylase
Inactivated by stomach acid (with food, enteric coating)

33
Q

Why do you need a high calorie diet?

A

for digestion

34
Q
A